Markets News, Dec. 22, 2023: Stocks Eke Out Eighth Consecutive Week of Gains

Traders work on the floor of the New York Stock Exchange (NYSE).

Michael Nagle / Bloomberg via Getty Images

Stocks just barely rose Friday to cap off their eighth straight winning week after the Fed's preferred inflation gauge showed prices fell for the first time since 2020 in November.

The Nasdaq and the 澳洲幸运5官方开奖结果体彩网:S&P 500 both gained about 0.2% Friday, while the 澳洲幸运5官方开奖结果体彩网:Dow Jones Industrial Average slipped less than 0.1%. For the week, the Nasdaq added 1.2%, the S&a👍mp;P 500 rose 0.7%, and th𝕴e Dow ticked up 0.2%.

The 澳洲幸运5官方开奖结果体彩网:pe𝄹rsona♛l consumption expenditures (PCE) price index 澳洲幸运🧸5官方开奖结果体彩网:ro🎀se 2.6% in the twelve months through November, the index's lowest reading since February 2021. On a month-over-month basis, the index fell, suggesting prices declined for the first time since 2020. Excluding volatile food and energy prices, the index rose 3.2%, less than the 3.3% increase economists were predicting. With Friday's report, the pace of core inflation has slowed to just 1.9% in the last six months, putting inflation on track to hit the Fed's 2% goal next year.

Shares of Dow component Nike (NKE) fell more t🧜han 10% after it slashed its full-year outlook, projecting sales growth of just 1% this year, down from a prior estimate of mid-single-digit growth.

Stocks 澳洲幸运5ꦬ官方开🌄奖结果体彩网:resumed their year-end rally yesterday after GDP and 🌼unemployment data raised convi💝ction the U.S. economy is coming in for that ever-illusive soft landing.

Equity Indexes Wrap: Nike Drags Down the Dow and Apparel Stocks; Pharmaceuticals Gain on Bristol Myers Squibb's Karuna Acquisition

December 22, 2023 04:18 PM EST

The Dow

Intel (INTC) led the index, rising 2% to close at a new one-yea🎐r high. 

Amgen (AMGN) gained 1.7%, followed closely behind by fellow pharmaceutical firm Merck & Co. (MRK), up 1.2%.

Walmart (WMT) rose 1.2%, making it one of several discount and low-cost retailers to outper🐭form t🦂oday.

Nike (NKE) tumbled 11.8% after announcing a $2 billion cost-cutting plan and l🍌owering its full-year sales outlook on softer-than-expected demand. 

Disney (DIS) shares fell 1.1%, followed by Apple (AAPL), down 0.6%.

The S&P 500

Engineering software firm Ansys (ANSS) ro🌳se 18.1% to lead the index higher following reports it was considering ꩵseveral acquisition offers. 

Albemarle (ALB) stock rose 3.2% as the lithium🌄 miner extended its rebound after hitti💝ng a three-year low in November.

Bristol Myers Squibb (BMY) rose 2% after it said it would acquire Karuna Therapeutics (KRTX) for about $14 billion. ꦺKaruna shares surged 47.4%.

Dollar General (DG) and competitor Dollar Tree (DLTR) both rose 1.7%, following Walmart stock higher.

Gold miner Newmont (NEM) gained 1🌱.5% as the price of gold ticked up.&nbs﷽p;

VF Corp (VFC), the owner of Vans and Timberland, fell 3.2%, weighed down by Nike’s grim outlook for the apparel sector. Clothing companies Ralph Lauren (RL) and Tapestry (TPR) slipped 1.7% and 1.4%, respectively. Beauty brands Ulta Beauty (ULTA) and Estée Lauder (EL) also lagged. 

Cummins (CMI) fell 2.9% after the engine maker agreed to pay nearly $1.7 billion in penalties for altering hundreds of thousands of pickup truck engines to circumvent air pollution regulations.

The Nasdaq 100

Moderna (MRNA) gained 4.1% as global h🍨ealth authorities warned of a new fast-sprea♏ding Covid variant, JN.1.

Micron Technology (MU) continued to climb after yesterday’s earnings beat. The stock rose 1.2% Friday🌟 to finish the week more than 6% higher.

Synopsis (SNPS) share🦋s fell 6.3% after Reuters reported it had submitted one of the aforeme🐲ntioned offers to acquire Ansys. 

The Trade Desk (TTD) fell 3.9%, part of a sluggish tech sector that finished the♊ day flat.

Bristol Myers Squibb Boosts Itꦗs Neuroscience Reach With $14 Billion Karuna Deal

December 22, 2023 02:50 PM EST

Karuna Therapeutics (KRTX) 澳洲幸运5官方开奖结果体彩网:shares skyrocketed over 46% after Bristol Myers Squibb (BMY) said it would buy the biopharmaceutical firm for $ꦿ14 billion t🧔o expand its neuroscience portfolio.

Bristol Myers Squibb said it would pay Karuna investors $330 in cash for every share they owned. That works out to a 53% premium to Karuna’s closing price yesterday.

The drug maker said that K𝐆aruna is developing medicin𒁃es for those suffering from psychological or neurological conditions and that its lead asset, the antipsychotic KarXT, “represents a significant revenue contribution opportunity.”

Karuna Therapeutics shares were up 47% to⛦ $316.50 per sh🌱are Friday afternoon. Shares of Bristol-Myers Squibb also advanced and were 1.8% higher at $52.16 per share.

-澳洲幸运5官方开奖结果体彩网:Bill McColl

Midday Movers

December 22, 2023 01:59 PM EST

Bristol Myers Squibb Co. (BMY): Shares of the pharmaceutical company rose about 3% after it said it would 澳洲幸运5官方开奖结果体彩网:pay $14 billion to acquire biopharma firm Karuna Therapeutics (KRTX) as it seeks to strengthen its neurology pipeline. Karuꦓna shares jumpജed 47%.

Moderna Inc. (MRNA): The vaccine maker’s ꦅshares rose more than 5% as🅠 health authorities warned of a fast-spreading Covid variant, JN.1. Moderna shares have risen more than 10% this week. 

Nike Inc. (NKE): Shares fell 11% after the company 澳洲幸运5官方开奖结果体彩网:slashed it🔥s full-year sales outlook and announced a $2 billion cost-cutting plan as it ༺confronts weakening sales. 

Cummins Inc. (CMI): Shares sank more than 2% as the en🅺gine maker agreed to pay $1.675 billion in penalties related to allegatio🍸ns it altered truck engines to circumvent air pollution rules.

Nike Plunges After Slashing Its O🍷utlook and Announcing Cost Cuts as Demand Softens

December 22, 2023 01:05 PM EST

Nike (NKE) was the worst-performing stock in the Dow and 澳洲幸运5官方开奖结果体彩网:S&P 500 as shares tumbled after the athletic apparel retailer 澳洲幸运5官方开奖结果体彩网:slashed its full-year outlook because of “softer” sales in the🎃 second half. It also announced plans to reduce costs, which could include layoffs.

The company now expects fiscal 2024 revenue to increase approximately 1%, down from its earlier forecast of rising by a mid-single-digit percentage.

CFO Matt Friend explained that the new guidance reflected “increased macro economic headwinds,” particularly in Greater China and Europe, the Middle East, and Africa. Friend added that the company plans to cut $2 billion in costs over the next three years, noting that savings would come from across the business, not just from 澳洲幸运5官方开奖结果体彩网:selling, general🦩, and administrative 🍃(SG&A) expenses.

Nike shares were🎶 down 11% Friday afternoon and were in negative territory fo🍌r the year.

-澳洲幸运5官方开奖结果体彩网:Bill McColl

NKE
TradingView.

Ansys Leads S&P 500 Following Reports of Potentialꦍ Acquisition

December 22, 2023 12:13 PM EST

Simulation software developer Ansys (ANSS) was the best-performing stock꧂ in the S&P 500 Friday following reports that the company was consi🤪dering a sale after being approached by at least one interested buyer. 

The company’s management is in discussion with advisors, according to a Bloomberg report that cited unidentified people familiar with the matter. T💃he company has not made a decision and could still decide to rebuff the inte🌟rest. 

Ansys makes engineering software that clients in industries ranging from aerospace and defense to semiconductors and medical tech use to design products and test them through simu༺lations. 

Ansys shares jumped nearly 17% at the open to tra෴de near a two-year high before retreating slightly. The stock was up about 9% in midday trading, putting it nearly 40% higher for the year.

Ansys year-to-date stock chart (Dec. 22, 2023)

Fed's Preferred Inflation Measure Slows in November

December 22, 2023 11:29 AM EST

The 澳洲幸运5官方开奖结果体彩网:Federal Reserve's preferred gauge of inflation slowed as income and spending were strong in November, the latest indi🌠cator pointing toward a soft landing.

The 澳洲幸运5官𒁏方开奖结果体彩网:personal consumptioꦰn expenditures (PCE) price index dropped 0.1% in its first decline since April 2020. The index was up 2.6%𒈔 from the same time last year but is nearer to the Fed's 2% goal and down from 2.9% in the prior month. That is the lowest rate since early 2021.

The core price index which excludes food and energy prices grew only 0.1%, the same as the month prior. Core PCE was up 3.2% from the same time last year, down from 澳洲幸运5官方开奖结果体彩网:3.4% the month prior.

The slowdown could bolster confidence that the Fed's anti-inflation rate hikes have delivered their desired outcome. It could also raise the odds that Fed officials will follow through with the 澳洲幸运5官方开奖结果体彩网:interest rate cuts they forecas▨ted for next year at their December meeting.

-澳洲幸运5官方开奖结果体彩网:Naomi Buchanan

Video Game Stocks Sink on China’s Proposed Gam🔴ing Regulations

December 22, 2023 10:46 AM EST

Chinese gaming stocks tumbled Friday morning after regul♕ators proposed new rules designed to curb the amount of time and money spent on vi🐭deo games. 

The rules, proposed by China’s National Press and Publication Administration, include an unspecified cap on how much players can spend within a game and banning developers from rewarding players for daily logins. The rules build on China’s already strict gaming regulations, which limit minors to playing video games between the hours of 8 p.m. and 9 p.m. on Friday, Saturday, Sunday, and statutory holidays.

Friday’s announcement came as a surprise to China’s gaming industry, which serves one of the world’s largest video markets. Chinese video game sales topped 300 billion yuan ($42.6 billion) in 2023.

Shares of Chinese gaming giants plummeted on the news. Shares of Tencent Holdings (TCEHY) trading over the counter fell more than 11%, while American depositary receipts of NetEase (NTES) slumped 17%. 

E-commerce companies Meituan (MPNGF) and Alibaba (BABA) fell 5% and 1%, respectively, amid concerns that Friday’s rules could signal the resumption of a government crackdown on big tech that started in 2020 and ha♈d seemed to wane in the last year.

Stocks Making the Biggest Moves Premarket

December 22, 2023 09:26 AM EST

Gains: 

  • Karuna Therapeutics Inc. (KRTX): Shares of the biopharmaceutical company jumped nearly 50% to about $318 after Bristol Myers Squibb (BMY) said it would buy the company for $330 a share, or about $14 billion. Bristol Myers Squibb shares slipped about 0.5% in early trading. 
  • Ansys Inc. (ANSS): Shares rose 22% amid reports the software company was considering a sale after receiving takeover interest from several potential buyers.
  • Rocket Lab USA Inc. (RKLB): Shares of the aerospace company gained more than 15% after it said it had won a $515 million contract from a government buyer.

Losses: 

  • NetEase Inc. (NTES): American depositary receipts of the Chinese gaming company fell more than 20% after Chinese regulators proposed new curbs on online gaming. Gaming and Chinese stocks followed NetEase lower on the news. 
  • Nike Inc. (NKE): Shares of the apparel company fell about 12% after it cut its sales outlook for the fiscal year and said it would implement a cost-cutting plan to save $2 billion in the next three years. Shoe retailer Foot Locker (FL) fell 7% alongside other apparel and sporting goods stocks. 

Stock Futures Rise as Data Shows Inflati𒁃on Slowed Again in November

December 22, 2023 08:52 AM EST

Futures contracts connected to the Dow Jones Industrial Average were💖 0.3% lower in early trading Friday.

Dow futures (Dec. 22, 2023)

S&P 500 futures were up 0.1%.

S&P 500 futures (Dec. 22, 2023)

Nasdaq 100 futures traded about 0.2% higher.

Nasdaq 100 futures (Dec. 22, 2023)
Article Sources
Investopedia requires writers to use primary sources to support their work. These include white papers, government data, original reporting, and interviews with industry experts. We also reference original research from other reputable publishers where appropriate. You can learn more about the standards we follow in producing accurate, unbiased content in our editorial policy.
  1. U.S. Bureau of Economic Analysis. "."

  2. Bristol Myers Squibb. "."

  3. Nike. "."

  4. Bloomberg. “.”

  5. Bloomberg. "."

  6. The New York Times. “.”

  7. Reuters. “.”

Compare Accounts
The offers that appear in this table are from partnerships from which Investopedia receives compensation. This compensation may impact how and where listings appear. Investopedia does not include all offers available in the marketplace.

Related Articles